Good afternoon :)
Place Order
Add to Watchlist

SMS Lifesciences India Ltd

SMSLIFE Share Price

1,081.250.72% (-7.80)

SMSLIFE Share Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹326 cr, stock is ranked 2,041
High RiskStock is 4.02x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹326 cr, stock is ranked 2,041
High RiskStock is 4.02x as volatile as Nifty

SMSLIFE Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
14.181.690.14%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.006.390.53%

SMSLIFE Analyst Ratings & Forecast

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

SMSLIFE Company Profile

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of organic and inorganic chemicals,pharmaceuticals

SMSLIFE Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
44.71
1Y Return
14.01%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
29.86
1Y Return
5.19%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
65.86
1Y Return
26.18%
Buy Reco %
68.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.93
1Y Return
2.08%
Buy Reco %
45.16
Mankind Pharma Ltd
MANKIND
PE Ratio
52.09
1Y Return
13.24%
Buy Reco %
80.00
Compare with Peers

SMSLIFE Forecasts

Price

Revenue

Earnings

SMSLIFE Share Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

SMSLIFE Company Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

SMSLIFE Stock EPS (Earnings Per Share) Forecast

Hmm, looks like data is unavailable here. Please come back after some time

SMSLIFE

Income

Balance Sheet

Cash Flow

SMSLIFE Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -4.02%, vs industry avg of 9.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.17% to 0.08%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of -12.6%, vs industry avg of 15.28%

Loading...

Financial YearFY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue380.36263.06267.37364.50320.98309.79350.50
Raw Materialssubtract268.79147.04135.17204.47171.33150.19296.64
Power & Fuel Costsubtract25.9320.4821.5630.0229.2830.46
Employee Costsubtract23.1126.5630.6639.9043.4349.27
Selling & Administrative Expensessubtract11.989.2812.2813.7712.5214.20
Operating & Other expensessubtract13.2832.0235.6827.3730.1830.62
Depreciation/Amortizationsubtract6.387.867.8610.0110.7914.9414.98
Interest & Other Itemssubtract5.515.154.606.236.8710.269.52
Taxes & Other Itemssubtract7.544.496.027.415.130.756.31
EPS59.0133.6744.7983.7537.8730.1076.24
DPS1.500.001.501.501.501.501.50
Payout ratio0.030.000.030.020.040.050.02
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

SMSLIFE Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

SMSLIFE Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
SMS Lifesciences India Ltd35.921.690.14%
Sun Pharmaceutical Industries Ltd44.716.380.76%
Cipla Ltd29.864.590.85%
Torrent Pharmaceuticals Ltd65.8615.910.87%

SMSLIFE Stock Price Comparison

Compare SMSLIFE with any stock or ETF
Compare SMSLIFE with any stock or ETF
SMSLIFE
Loading...

SMSLIFE Shareholdings

SMSLIFE Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

SMSLIFE Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

SMSLIFE Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.41%0.00%0.00%0.00%28.59%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

SMSLIFE Shareholding History

SepDec '23MarJunSepDec '240.00%0.00%0.00%0.01%0.02%0.00%

SMSLIFE Insider Trades & Bulk Stock Deals

Loading...

smallcases containing SMSLIFE stock

Looks like this stock is not in any smallcase yet.

SMSLIFE Events

SMSLIFE Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

SMSLIFE Upcoming Dividends

No upcoming dividends are available

SMSLIFE Past Dividends

Cash Dividend

Ex DateEx DateSep 23, 2024

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 23, 2024

Cash Dividend

Ex DateEx DateSep 22, 2023

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 22, 2023

Cash Dividend

Ex DateEx DateSep 22, 2022

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 22, 2022

Cash Dividend

Ex DateEx DateSep 20, 2021

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 20, 2021

Cash Dividend

Ex DateEx DateSep 19, 2019

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 19, 2019

SMSLIFE Stock News & Opinions

Spotlight
SMS Lifesciences India spurts as Q3 PAT jumps 18% YoY to Rs 5 cr

Revenue from operations was at Rs 84.60 crore in the third quarter of FY25, marking a growth of 17.41% compared with Rs 72.05 crore in Q3 FY24. In Q3 FY25, the profit before tax (PBT) spiked 81.36% year on year (YoY) to Rs 6.91 crore. Total expenses added 12.96% YoY to Rs 77.74 crore in the quarter ended 31 December 2024. Cost of materials consumed was at Rs 39.43 crore (up 0.61% YoY), and employee benefits expense was at Rs 14.60 crore (up 9.69% YoY) during the period under review. On a nine-month basis, the company reported consolidated net profit of Rs 15.24 crore in 9M FY25, compared with net loss of Rs 0.14 crore posted in 9M FY24. Revenue from operations jumped 18.35% YoY to Rs 255.61 crore in 9M FY25. Meanwhile, the board has approved the reappointment of Veeravenkata Satyanarayana Murthy Talluri as managing director (MD) of the company for a further period of 3 consecutive year's w.e.f. 1 June 2025. SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents, and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API), and intermediates. Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
SMS Lifesciences India consolidated net profit rises 27.21% in the December 2024 quarter

Net profit of SMS Lifesciences India rose 27.21% to Rs 5.47 crore in the quarter ended December 2024 as against Rs 4.30 crore during the previous quarter ended December 2023. Sales rose 17.42% to Rs 84.60 crore in the quarter ended December 2024 as against Rs 72.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales84.6072.05 17 OPM %15.0712.89 - PBDT10.677.54 42 PBT6.923.81 82 NP5.474.30 27 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
SMS Lifesciences India consolidated net profit rises 586.76% in the September 2024 quarter

Net profit of SMS Lifesciences India rose 586.76% to Rs 4.67 crore in the quarter ended September 2024 as against Rs 0.68 crore during the previous quarter ended September 2023. Sales rose 13.28% to Rs 78.46 crore in the quarter ended September 2024 as against Rs 69.26 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales78.4669.26 13 OPM %10.9111.45 - PBDT8.475.39 57 PBT4.701.66 183 NP4.670.68 587 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
SMS LifeSciences India to conduct board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
SMS LifeSciences India AGM scheduled

SMS LifeSciences India announced that the 18th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
SMS Lifesciences India reports consolidated net profit of Rs 7.00 crore in the June 2024 quarter

Net profit of SMS Lifesciences India reported to Rs 7.00 crore in the quarter ended June 2024 as against net loss of Rs 1.80 crore during the previous quarter ended June 2023. Sales rose 23.98% to Rs 92.55 crore in the quarter ended June 2024 as against Rs 74.65 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales92.5574.65 24 OPM %17.593.39 - PBDT14.320.97 1376 PBT10.64-2.73 LP NP7.00-1.80 LP Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
SMS LifeSciences India schedules board meeting

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live

SMS Lifesciences India consolidated net profit rises 59.80% in the March 2022 quarter

2 years agoBusiness Standard

SMS Lifesciences India divests 10% stake of wholly-owned subsidiary, Mahi Drugs

2 years agoBusiness Standard

Frequently asked questions

  1. What is the share price of SMS Lifesciences India Ltd (SMSLIFE) today?

    The share price of SMSLIFE as on 21st March 2025 is ₹1081.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on SMS Lifesciences India Ltd (SMSLIFE) share?

    The past returns of SMS Lifesciences India Ltd (SMSLIFE) share are
    • Past 1 week: 14.19%
    • Past 1 month: -8.55%
    • Past 3 months: -10.17%
    • Past 6 months: -28.54%
    • Past 1 year: 62.46%
    • Past 3 years: 51.30%
    • Past 5 years: 514.17%

  3. What are the peers or stocks similar to SMS Lifesciences India Ltd (SMSLIFE)?

    The peers or stocks similar to SMS Lifesciences India Ltd (SMSLIFE) include:

  4. What is the dividend yield % of SMS Lifesciences India Ltd (SMSLIFE) share?

    The current dividend yield of SMS Lifesciences India Ltd (SMSLIFE) is 0.14.

  5. What is the market cap of SMS Lifesciences India Ltd (SMSLIFE) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of SMS Lifesciences India Ltd (SMSLIFE) is ₹326.89 Cr as of 21st March 2025.

  6. What is the 52 week high and low of SMS Lifesciences India Ltd (SMSLIFE) share?

    The 52-week high of SMS Lifesciences India Ltd (SMSLIFE) is ₹1749.65 and the 52-week low is ₹612.15.

  7. What is the PE and PB ratio of SMS Lifesciences India Ltd (SMSLIFE) stock?

    The P/E (price-to-earnings) ratio of SMS Lifesciences India Ltd (SMSLIFE) is 35.92. The P/B (price-to-book) ratio is 1.69.

  8. Which sector does SMS Lifesciences India Ltd (SMSLIFE) belong to?

    SMS Lifesciences India Ltd (SMSLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy SMS Lifesciences India Ltd (SMSLIFE) shares?

    You can directly buy SMS Lifesciences India Ltd (SMSLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.